ARDELYX, INC. Amortization of Debt Discount (Premium)
ARDELYX, INC. (ARDX) reported Amortization of Debt Discount (Premium) of $3.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-06
- ARDELYX, INC. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $1.57M, a 31.50% decline year-over-year.
- ARDELYX, INC. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $1.58M, a 25.94% decline year-over-year.
- ARDELYX, INC. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $2.08M, a 5.10% increase year-over-year.
- ARDELYX, INC. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $2.45M, a 22.05% increase year-over-year.
- ARDELYX, INC. amortization of debt discount (premium) for fiscal 2025 was $8.96M, a 21.05% increase from fiscal 2024.
- ARDELYX, INC. amortization of debt discount (premium) for fiscal 2024 was $7.40M, a 75.36% increase from fiscal 2023.
- ARDELYX, INC. amortization of debt discount (premium) for fiscal 2023 was $4.22M, a 115.09% increase from fiscal 2022.
- ARDELYX, INC. amortization of debt discount (premium) for fiscal 2022 was $1.96M, a 593.29% increase from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.15M 10-Q · filed 2026-08-06 | $5.23M derived: sum of 3 quarters · filed 2026-08-06 | $7.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.58M 10-Q · filed 2026-04-30 | $3.66M derived: sum of 2 quarters · filed 2026-04-30 | $6.12M derived: sum of 3 quarters · filed 2026-04-30 | $8.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.53M derived: sum of 2 quarters · filed 2026-02-19 | $6.82M derived: sum of 3 quarters · filed 2026-08-06 | $8.96M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.74M derived: sum of 2 quarters · filed 2026-08-06 | $6.88M 10-Q · filed 2025-10-30 | $8.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.42M 10-Q · filed 2026-08-06 | $6.41M derived: sum of 3 quarters · filed 2026-08-06 | $8.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.14M 10-Q · filed 2026-04-30 | $4.12M derived: sum of 2 quarters · filed 2026-04-30 | $6.13M derived: sum of 3 quarters · filed 2026-04-30 | $7.78M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.99M derived: sum of 2 quarters · filed 2026-02-19 | $5.65M derived: sum of 3 quarters · filed 2026-02-19 | $7.40M 10-K · filed 2026-02-19 |
| 2024-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.67M derived: sum of 2 quarters · filed 2025-10-30 | $5.42M 10-Q · filed 2025-10-30 | $6.55M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $3.41M 10-Q · filed 2025-08-04 | $4.54M derived: sum of 3 quarters · filed 2026-02-19 | $5.54M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.75M 10-Q · filed 2025-05-01 | $2.88M derived: sum of 2 quarters · filed 2026-02-19 | $3.88M derived: sum of 3 quarters · filed 2026-02-19 | $4.93M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.13M derived: sum of 2 quarters · filed 2026-02-19 | $3.18M derived: sum of 3 quarters · filed 2026-02-19 | $4.22M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $2.05M derived: sum of 2 quarters · filed 2024-10-31 | $3.09M 10-Q · filed 2024-10-31 | $4.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.09M 10-Q · filed 2024-08-01 | $3.00M derived: sum of 3 quarters · filed 2025-02-20 | $3.90M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-02 | $1.95M derived: sum of 2 quarters · filed 2025-02-20 | $2.85M derived: sum of 3 quarters · filed 2025-02-20 | $2.90M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.81M derived: sum of 2 quarters · filed 2025-02-20 | $1.85M derived: sum of 3 quarters · filed 2025-02-20 | $1.96M 10-K · filed 2025-02-20 |
| 2022-09-30 | $904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $946.00K derived: sum of 2 quarters · filed 2023-10-31 | $1.05M 10-Q · filed 2023-10-31 | $1.13M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $151.00K 10-Q · filed 2023-08-02 | $222.00K derived: sum of 3 quarters · filed 2024-02-22 | $293.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $109.00K 10-Q · filed 2023-05-03 | $180.00K derived: sum of 2 quarters · filed 2024-02-22 | $251.00K derived: sum of 3 quarters · filed 2024-02-22 | $322.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $142.00K derived: sum of 2 quarters · filed 2024-02-22 | $213.00K derived: sum of 3 quarters · filed 2024-02-22 | $283.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $142.00K derived: sum of 2 quarters · filed 2022-11-03 | $212.00K 10-Q · filed 2022-11-03 | $232.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $141.00K 10-Q · filed 2022-08-04 | $161.00K derived: sum of 3 quarters · filed 2023-03-02 | $297.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $70.00K 10-Q · filed 2022-05-05 | $90.00K derived: sum of 2 quarters · filed 2023-03-02 | $226.00K derived: sum of 3 quarters · filed 2023-03-02 | $356.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $156.00K derived: sum of 2 quarters · filed 2023-03-02 | $286.00K derived: sum of 3 quarters · filed 2023-03-02 | $413.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $266.00K derived: sum of 2 quarters · filed 2021-11-12 | $393.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $257.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $127.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $478.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |